Sucampo to be Added to NASDAQ Biotechnology Index

Sucampo Pharmaceuticals SCMP (SPI) today announced that NASDAQ OMX Group, Inc. NDAQ will include the company in the NASDAQ Biotechnology Index® NBI effective prior to market open on Monday, May 20, 2013. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a modified market capitalization weighted index. Among the various criteria that must be met in order to be eligible for inclusion in this index are a market capitalization of at least $200 million and an average daily trading See full press release